Abstract
was substituted for IGF-I(SD), the relationships became more intense (for men, HR=0.47, 95%CI 0.33–0.65, p< 0.001; for women, HR=0.50, 95%CI 0.27–0.91, p = 0.024). Conclusion: The present study showed that lower serum IGF-I levels were associated with the increased all-cause mortality in patients with type 2 diabetes mellitus, suggesting that serum IGF-I could be clinically useful for assessing the risk of mortality in the population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
